The Atriva Management
Christian Pangratz
Incoming CEO
25 years of proven track record in management and commercial functions of globally active life sciences companies. Chief Executive Officer of Sterna Biologicals, Managing Director at Secarna Pharmaceuticals, Sr. VP at Vectura Group, Executive VP at SkyePharma, Chief Business Officer at Activaero, Exec. Dir. at Nektar Therapeutics. Raised funds in excess of €250 Mn through Business/Corporate Development and financing transactions.
Rainer Lichtenberger, Ph.D.,
MBA
Outgoing CEO
30 years management in life science Industry, VP Global Marketing, Merck, EVP ratiopharm group for New Business. Since 16 years CEO experience in SME and biotech, raised € 80 Mn funds, involved in € 200+ Mn deal volume.
Stephan Stenglein, M.D.,
CMO & EVP Clinical Development
Physician trained in Clinical and Molecular Virology with 20 years of accomplishments in pharma, medical device and vaccine development. Previous global management positions with Novartis and AstraZeneca.
Nigel Horscroft, D.Phil.
CSO & EVP Preclinical Research
20 years of management experience in research in positions of increasing seniority with big Pharma (Pfizer) and SMEs (Valeant, CureVac), in antivirals and vaccines. DPhil in Biochemistry from Oxford University and post-doc at University of California (Lipkin lab). 20+ publications and several patents.
Christian Wallasch, Ph.D., CDO/COO & EVP
Preclinical Development
20 years senior management experience (COO, CEO) in SMEs (Axxima, GPC Biotech and public companies (Intercel/Valneva)). Proven track record in the preclinical/clinical development of kinase inhibitors and vaccines, project-management and -execution.
Cees Stouten, M.Sc.,
SVP Chemistry Manufacturing Controls,
Site Manager Atriva Therapeutics BV
Accomplished CMC manager with long-standing and deep experience along the entire development, manufacturing and control value chain,
more than 20 years industry experience